Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells

Oncogene

Volumn 22, Issue 55, 2003, Pages 8924-8930

  Balachandran, Raghavan ^a   Welsh, Manda J ^a   Day, Billy W ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b 721 Salk Hall ^*  (United States)

Author keywords

Microtubules; p21WAF1; p53; Stathmin

Indexed keywords

BETA TUBULIN; PACLITAXEL; PROTEIN P21; PROTEIN P53; STATHMIN; TUBULIN; VERAPAMIL;

ADENOVIRUS; ALLELE; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL CYCLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROTUBULE; OVARY CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE PROTEINS; OVARIAN NEOPLASMS; PACLITAXEL; PHOSPHOPROTEINS; STATHMIN;

ADENOVIRIDAE;

EID: 0347994021     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207060     Document Type: Article

References (45)

1. Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ and George DL. (1999). Oncogene, 18, 5954-5958.
2. Alli E, Bash-Babula J, Yang JM and Hait WN. (2002). Cancer Res., 62, 6864-6869.
3. Andersen SS. (1999). BioEssays, 21, 53-60.
4. Andersen SS. (2000). Trends Cell Biol., 10, 261-267.
5. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R and Curmi PA. (1998). Br. J. Cancer, 78, 701-709.
6. Brattsand G. (2000). Br. J. Cancer, 83, 311-318.
7. Cheon MS, Fountoulakis M, Cairns NJ, Dierssen M, Herkner K and Lubec G. (2001). J. Neural Transm. Suppl., 61, 281-288.
8. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R and Bieche I. (2000). Br. J. Cancer, 82, 142-150.
9. Di Paolo G, Pellier V, Catsicas M, Antonsson B, Catsicas S and Grenningloh G. (1996). J. Cell Biol., 133, 1383-1390.
10. Downing K. (2000). Annu. Rev. Cell Dev. Biol., 16, 89-111.
11. Friedrich B, Gronberg H, Landstrom M, Gullberg M and Bergh A. (1995). Prostate, 27, 102-109.
12. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P and Sobel A. (1998). J. Cell Sci., 111, 3333-3346.
13. Giannakakou P, Poy G, Zhan Z, Knutsen T, Blagosklonny MV and Fojo T. (2000). Oncogene, 19, 3078-3085.
14. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JTM, Fojo T and Poruchynsky MS. (1997). J. Biol. Chem., 272, 17118-17125.
15. Gradin HM, Larsson N, Marklund U and Gullberg M. (1998). J. Cell Biol., 140, 131-141.
16. Gu Y, Turck CW and Morgan DO. (1993). Nature, 366, 707-710.
17. Howell B, Deacon H and Cassimeris L. (1999). J. Cell Sci., 112, 3713-3722.
18. Horwitz SB, Shen HJ, He L, Dittmar P, Neef R, Chen J and Schubart UK. (1997). J. Biol. Chem., 212, 8129-8132.
19. Hummert TW, Schwartz Z, Sylvia VL, Dean DD, Hardin RR and Boyan BD. (2000). J. Cell. Biochem., 79, 150-163.
20. Iancu C, Mistry SJ, Arkin S and Atweh GF. (2000). Cancer Res., 60, 3537-3541.
21. Ji H, Baldwin GS, Burgess AW, Moritz RL, Ward LD and Simpson RJ. (1993). J. Biol. Chem., 268, 13396-13405.
22. Jimenez GS, Khan HS, Stommel JM and Wahl GM. (1999). Oncogene, 18, 7656-7665.
23. Johnsen JI, Aurelio ON, Kwaja Z, Jorgensen GE, Pellegata NS, Plattner R and Stanbridge EJ. Cajot JF. (2000). Int. J. Cancer, 88, 685-691.
24. Johnson WE, Jones NA, Rowlands, DC, Williams A, Guest SS and Brown G. (1995). FEBS Lett., 364, 309-313.
25. Johnsson A, Zeelenberg I, Min Y, Hilinski J, Berry C, Howell SB and Los G. (2000). Br. J. Cancer, 83, 1047-1054.
26. Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH and Seth P. (1995). Clin. Cancer Res., 1, 889-897.
27. Larsson N, Melander H, Marklund U, Osterman R and Gullberg M. (1995). J. Biol. Chem., 270, 14175-14183.
28. Larsson N, Segerman B, Gradin H, Wandizioch E, Cassimeris L and Gullberg M. (1999). Mol. Cell. Biol., 19, 2242-2250.
29. Lawler S. (1998). Curr. Biol., 8, R212-R214.
30. Lewis TS, Hunt JB, Aveline LD, Hunt JB, Aveline LD, Jonscher KR, Louie DF, Yeh JM, Nahreini TS, Resing KA and Ahn NG. (2000). Mol. Cell, 6, 1343-1354.
31. Liedtke W, Leman EE, Fyffe REW, Raine CS and Schubart UK. (2002). Am. J. Pathol., 160, 469-480.
32. Marklund U, Osterman O, Melander H, Bergh A and Gullberg M. (1994). J. Biol. Chem., 269, 30626-30635.
33. McNally FJ. (1996). Curr. Opin. Cell Biol., 8, 23-29.
34. Michalak M, Corbett EF, Mesaeli N, Nakamura K and Opas M. (1999). Biochem. J., 344, 281-292.
35. Mistry SJ and Atweh GF. (2001). J. Biol. Chem., 276, 31209-31215.
36. Moreno FJ and Avila J. (1998). Mol. Cell Biochem., 183, 201-209.
37. Murphy M, Ahn J, Walker KK, Hoffaman WH, Evans RM, Levine AJ and George DL. (1999). Genes Dev., 13, 2490-2501.
38. Poruchynsky MS, Giannakakou P, Ward Y, Bulinski JC, Telford WG, Robey RW and Fojo T. (2001). Biochem. Pharmacol., 62, 1469-1480.
39. Price DK, Ball JR, Bahrani-Mostafavi Z, Vachris JC, Kaufman JS, Naumann RW, Higgins RV and Hal JB. (2000). Cancer Invest., 18, 722-730.
40. Reed JC. (1995). Curr. Opin. Oncol., 7, 541-546.
41. Rowlands DC, Williams A, Jones NA, Guest SS, Reynolds GM, Barber PC and Brown G. (1995). Lab. Invest., 72, 100-113.
42. Steinman RA, Yaroslavsky B, Kaplan SS, Goff JP and Shields DS. (2000). Leuk. Res., 24, 601-610.
43. Vancompernolle K, Boonefaes T, Mann M, Fiers W and Grooten J. (2000). J. Biol. Chem., 275, 33876-33882.
44. Walczak CE. (2000). Curr. Opin. Cell Biol., 12, 52-56.
45. Wallon G, Rappsilber J, Mann M and Serrano L. (2000). EMBO J., 19, 213-222.